Nora Brennan

Chief Financial Officer, TELA Bio, Inc.

Companies

Traws Pharma, Inc.Chief financial officer Feb 7, 2025 to Apr 8, 2026¹
Spectrum PharmaceuticalsOfficer Jan 5, 2023 to Aug 1, 2023²
Spectrum PharmaceuticalsChief financial officer Jun 23, 2022 to May 30, 2023³
Spectrum PharmaceuticalsBoard member Dec 14, 2020 to Jun 22, 2021⁴
TELA Bio, Inc.Chief financial officer Nov 7, 2019 to Apr 2, 2021⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Spectrum Pharmaceuticals SPPI0 shares⁶Jul 31, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 31, 2023Returned to company 463,005 shares of Spectrum Pharmaceuticals⁶
Jul 31, 2023Returned to company 104,823 shares of Spectrum Pharmaceuticals⁶
May 26, 2023Sold 32,387 shares at $1.10 of Spectrum Pharmaceuticals⁷
Jan 3, 2023Granted 240,000 shares of Spectrum Pharmaceuticals⁸
Jun 21, 2022Sold 3,569 shares at $0.79 of Spectrum Pharmaceuticals⁹
Jun 21, 2022Granted 334,507 shares of Spectrum Pharmaceuticals⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTraws Pharma, Inc., Chief financial officer
2
SEC EDGARSpectrum Pharmaceuticals, Officer
3
SEC EDGARSpectrum Pharmaceuticals, Chief financial officer
4
SEC EDGARSpectrum Pharmaceuticals, Board member
5
SEC EDGARTELA Bio, Inc., Chief financial officer
6
SEC EDGARSpectrum Pharmaceuticals shares after the filing of Jul 31, 2023
7
SEC EDGARForm 4 filed May 30, 2023
8
SEC EDGARForm 4 filed Jan 5, 2023
9
SEC EDGARForm 4 filed Jun 23, 2022